查詢結果分析
來源資料
相關文獻
- Weekly Doxorubicin with Tegafur-Uracil Slowed Progression of Metastatic Hepatocelluar Carcinoma in Schizophrenia Patients
- Successful Treatment of a Bulky Seminoma in an Abdominal Undescended Testis: A Case Report
- Ifosfamide-Based Chemotherapy for Previously Treated Lung Cancer Patients
- Treatment of Ultra-High Risk Gestational Trophoblastic Disease by an EMA/CE Regimen
- The Experience of Combination of Chemotherapy and Surgery in Treatment of Advanced Nonseminomatous Germ Cell Tumor of the Testis
- Malignant Primary Extragonadal Germ Cell Tumors of Mediastinum--An Analysis of Clinical and Radiological Features in 15 Cases
- 非小細胞肺癌術前輔助性化學治療的經驗
- Radiation Therapy in Primary Central Nervous System Lymphoma
- 精神科病例討論
- 精神分裂症與治療藥物
頁籤選單縮合
題名 | Weekly Doxorubicin with Tegafur-Uracil Slowed Progression of Metastatic Hepatocelluar Carcinoma in Schizophrenia Patients=轉移性肝癌合併精神分裂病患之治療經驗之分享:使用每周性速溶艾黴素(Doxorubicin)及友復膠囊(UFUR) |
---|---|
作者 | 張悅詩; 黃仁聖; 葉光揚; Chang, Yueh-shih; Huang, Jen-seng; Yeh, Kun-yun; |
期刊 | 臺灣癌症醫學雜誌 |
出版日期 | 20131200 |
卷期 | 29:4 2013.12[民102.12] |
頁次 | 頁206-211 |
分類號 | 416.246、416.246 |
語文 | eng |
關鍵詞 | 轉移性肝癌; 精神分裂症; 化學治療; Metastatic hepatocellular carcinoma; Schizophrenia; Chemotherapy; |
中文摘要 | 精神分裂症病患合併腫瘤之治療是複雜的,除了考慮療效,更多需要重視的是精神 疾病之控制及藥物與藥物間的副作用。本文分享兩位轉移性肝癌合併精神分裂患者之肝 癌治療經驗,在使用每周性速溶艾黴素(Doxorubicin)及友復膠囊(UFUR)之控制下,除了 延長生存時間,也有好的病患之藥物順從性及忍受性,此外,初步結果顯示不會干擾病 患精神狀況及疾病控制。此組合性治療可提供轉移性肝癌合併精神分裂之患者除了蕾莎 瓦(Sorafenib)之外之另一個選擇。 |
英文摘要 | We herein reported on 2 schizophrenia patients comorbid with metastatic hepatocellular carcinoma (HCC) who received palliative chemotherapy using weekly doxorubicin (30 mg/m2 on day 1, day 8 and day 15 every 4 weeks) and tegafur-uracil (400 mg/day, 5 days every week). After 6 months of treatment, the metastatic HCC responded favorably to treatment and reached a stable disease status (according to the World Health Organization criteria), and survival extended over 18 months for both patients. The chemotherapy toxicity was well-tolerated and psychotic symptoms were controlled throughout the treatment period. Close cooperation between oncologist and psychiatrist is helpful to most effectively pursue the chemotherapy schedule and obtain survival benefit. This combination chemotherapy could be a treatment alternative for metastatic HCC in schizophrenia patients who were unsuitable for Sorafenib use. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。